237 related articles for article (PubMed ID: 12525272)
1. Ergotamine and dihydroergotamine: a review.
Bigal ME; Tepper SJ
Curr Pain Headache Rep; 2003 Feb; 7(1):55-62. PubMed ID: 12525272
[TBL] [Abstract][Full Text] [Related]
2. Ergotamine, dihydroergotamine: current uses and problems.
Tfelt-Hansen P
Curr Med Res Opin; 2001; 17 Suppl 1():s30-4. PubMed ID: 12463275
[TBL] [Abstract][Full Text] [Related]
3. The 5-HT
Whealy M; Becker WJ
Handb Clin Neurol; 2024; 199():17-42. PubMed ID: 38307644
[TBL] [Abstract][Full Text] [Related]
4. Headache currents commentary.
Peatfield R
Headache; 2012 Apr; 52(4):715. PubMed ID: 22414189
[TBL] [Abstract][Full Text] [Related]
5. Dihydroergotamine, ergotamine, methysergide and sumatriptan - basic science in relation to migraine treatment.
Dahlöf C; Maassen Van Den Brink A
Headache; 2012 Apr; 52(4):707-14. PubMed ID: 22444161
[TBL] [Abstract][Full Text] [Related]
6. Ergotamine tartrate and dihydroergotamine mesylate: safety profiles.
Lipton RB
Headache; 1997; 37 Suppl 1():S33-41. PubMed ID: 9009472
[TBL] [Abstract][Full Text] [Related]
7. Safety and efficacy of ergotamine tartrate and dihydroergotamine in the treatment of migraine and status migrainosus. Working Panel of the Headache and Facial Pain Section of the American Academy of Neurology.
Silberstein SD; Young WB
Neurology; 1995 Mar; 45(3 Pt 1):577-84. PubMed ID: 7898722
[No Abstract] [Full Text] [Related]
8. Acute treatment of migraine attacks.
Ferrari MD; Haan J
Curr Opin Neurol; 1995 Jun; 8(3):237-42. PubMed ID: 7551126
[TBL] [Abstract][Full Text] [Related]
9. Coronary side-effect potential of current and prospective antimigraine drugs.
MaassenVanDenBrink A; Reekers M; Bax WA; Ferrari MD; Saxena PR
Circulation; 1998 Jul; 98(1):25-30. PubMed ID: 9665056
[TBL] [Abstract][Full Text] [Related]
10. Sumatriptan. An updated review of its use in migraine.
Perry CM; Markham A
Drugs; 1998 Jun; 55(6):889-922. PubMed ID: 9617601
[TBL] [Abstract][Full Text] [Related]
11. [Improper equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Ferrari MD; Haan J; Bax WA; van Coevorden RS; Timmerman H; Meijler WJ
Ned Tijdschr Geneeskd; 1993 Apr; 137(17):846-50. PubMed ID: 8387648
[No Abstract] [Full Text] [Related]
12. [Multiple value of sumatriptan above that of ergot alkaloids still not proven].
Ferrari MD; Haan J; Bax W; van Coevorden RS; van Huijgevoort JA; Timmerman H; Meyler WJ
Ned Tijdschr Geneeskd; 1994 Feb; 138(9):479-80. PubMed ID: 8133950
[No Abstract] [Full Text] [Related]
13. [Unjustified equalization of sumatriptan with ergotamine and dihydroergotamine in the Drug Equivalency System].
Van Mil JW
Ned Tijdschr Geneeskd; 1993 Jun; 137(24):1213-4. PubMed ID: 8391659
[No Abstract] [Full Text] [Related]
14. [Treatment of the acute migraine attack].
Titus F
Rev Neurol; 1995; 23 Suppl 2():S203-7. PubMed ID: 7497289
[No Abstract] [Full Text] [Related]
15. History of the use of ergotamine and dihydroergotamine in migraine from 1906 and onward.
Tfelt-Hansen PC; Koehler PJ
Cephalalgia; 2008 Aug; 28(8):877-86. PubMed ID: 18460007
[TBL] [Abstract][Full Text] [Related]
16. A double-blind study of subcutaneous dihydroergotamine vs subcutaneous sumatriptan in the treatment of acute migraine.
Winner P; Ricalde O; Le Force B; Saper J; Margul B
Arch Neurol; 1996 Feb; 53(2):180-4. PubMed ID: 8639069
[TBL] [Abstract][Full Text] [Related]
17. Symptomatic treatment of migraine in children: a systematic review of medication trials.
Damen L; Bruijn JK; Verhagen AP; Berger MY; Passchier J; Koes BW
Pediatrics; 2005 Aug; 116(2):e295-302. PubMed ID: 16061583
[TBL] [Abstract][Full Text] [Related]
18. Appropriate use of ergotamine tartrate and dihydroergotamine in the treatment of migraine: current perspectives.
Young WB
Headache; 1997; 37 Suppl 1():S42-5. PubMed ID: 9009473
[TBL] [Abstract][Full Text] [Related]
19. Sumatriptan. A reappraisal of its pharmacology and therapeutic efficacy in the acute treatment of migraine and cluster headache.
Plosker GL; McTavish D
Drugs; 1994 Apr; 47(4):622-51. PubMed ID: 7516861
[TBL] [Abstract][Full Text] [Related]
20. Dihydroergotamine: role in the treatment of migraine.
Schürks M
Expert Opin Drug Metab Toxicol; 2009 Sep; 5(9):1141-8. PubMed ID: 19624283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
